Literature DB >> 2120801

Radioimmunoassay of 3 alpha-hydroxy-5 alpha-pregnan-20-one in rat and human plasma.

R H Purdy1, P H Moore, P N Rao, N Hagino, T Yamaguchi, P Schmidt, D R Rubinow, A L Morrow, S M Paul.   

Abstract

A radioimmunoassay for measuring 3 alpha-hydroxy-5 alpha-pregnan-20-one in plasma has been developed. Polyclonal antibodies were raised in rabbits against 3 alpha-hydroxy-20-oxo-5 alpha-pregnan-11 alpha-yl carboxymethyl ether coupled to bovine serum albumin. 3 alpha-Hydroxy-5 alpha-pregnan-20-one was purified from either extracts of plasma by high-performance liquid chromatography. These antibodies were then used for the radioimmunoassay of this centrally active progesterone metabolite in rat and human plasma. 3 alpha-Hydroxy-5 alpha-pregnan-20-one was detected in plasma from female rats on the day of estrus (2.0 to 9.3 ng/ml) and in the plasma of women during the luteal phase of the menstrual cycle at levels ranging from 0.25 to 2.5 ng/ml. The latter was highly correlated with plasma progesterone levels.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2120801     DOI: 10.1016/0039-128x(90)90031-6

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  50 in total

1.  Inhibiting progesterone metabolism in the hippocampus of rats in behavioral estrus decreases anxiolytic behaviors and enhances exploratory and antinociceptive behaviors.

Authors:  M E Rhodes; C A Frye
Journal:  Cogn Affect Behav Neurosci       Date:  2001-09       Impact factor: 3.282

2.  Juvenile offspring of rats exposed to restraint stress in late gestation have impaired cognitive performance and dysregulated progestogen formation.

Authors:  Jason J Paris; Cheryl A Frye
Journal:  Stress       Date:  2010-10-31       Impact factor: 3.493

3.  Neurosteroid modulation of GABAergic neurotransmission in the central amygdala: a role for NMDA receptors.

Authors:  Chunsheng Wang; Christine E Marx; A Leslie Morrow; Wilkie A Wilson; Scott D Moore
Journal:  Neurosci Lett       Date:  2007-01-05       Impact factor: 3.046

4.  Allopregnanolone concentration and mood--a bimodal association in postmenopausal women treated with oral progesterone.

Authors:  Lotta Andréen; Inger Sundström-Poromaa; Marie Bixo; Sigrid Nyberg; Torbjörn Bäckström
Journal:  Psychopharmacology (Berl)       Date:  2006-05-25       Impact factor: 4.530

5.  Progesterone's effects to reduce anxiety behavior of aged mice do not require actions via intracellular progestin receptors.

Authors:  C A Frye; K Sumida; B C Dudek; J P Harney; J P Lydon; B W O'Malley; D W Pfaff; M E Rhodes
Journal:  Psychopharmacology (Berl)       Date:  2006-03-15       Impact factor: 4.530

6.  Female mice with deletion of Type One 5α-reductase have reduced reproductive responding during proestrus and after hormone-priming.

Authors:  Carolyn J Koonce; Cheryl A Frye
Journal:  Pharmacol Biochem Behav       Date:  2014-03-18       Impact factor: 3.533

Review 7.  Action by and sensitivity to neuroactive steroids in menstrual cycle related CNS disorders.

Authors:  Anna-Carin N-Wihlbäck; Inger Sundström-Poromaa; Torbjörn Bäckström
Journal:  Psychopharmacology (Berl)       Date:  2005-12-15       Impact factor: 4.530

8.  Increasing 3alpha,5alpha-THP following inhibition of neurosteroid biosynthesis in the ventral tegmental area reinstates anti-anxiety, social, and sexual behavior of naturally receptive rats.

Authors:  Cheryl A Frye; Jason J Paris; Madeline E Rhodes
Journal:  Reproduction       Date:  2008-09-25       Impact factor: 3.906

9.  Progestogens and estrogen influence impulsive burying and avoidant freezing behavior of naturally cycling and ovariectomized rats.

Authors:  Danielle C Llaneza; Cheryl A Frye
Journal:  Pharmacol Biochem Behav       Date:  2009-05-14       Impact factor: 3.533

10.  GABAA-receptor-mediated effects of progesterone, its ring-A-reduced metabolites and synthetic neuroactive steroids on neurogenic oedema in the rat meninges.

Authors:  V Limmroth; W S Lee; M A Moskowitz
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.